Key result
Home-based cardiac rehab matches centre-based care for VO2 peak, with greater gains in AF.
Why the study?
Centre-based cardiac rehabilitation uptake remains globally suboptimal due to logistical and geographic barriers. Home-based cardiac rehabilitation has emerged as an alternative model, prompting quantification of its comparative efficacy across aerobic capacity, functional mobility, and body composition.
Does home-based cardiac rehabilitation improve 12-week peak oxygen uptake, six-minute walk distance, and body mass index compared to centre-based cardiac rehabilitation in patients with coronary artery disease, heart failure, and atrial fibrillation?
Meta-Analysis (n=720)
Does home-based cardiac rehabilitation improve 12-week peak oxygen uptake, six-minute walk distance, and body mass index compared to centre-based cardiac rehabilitation in patients with coronary artery disease, heart failure, and atrial fibrillation?
Home-based cardiac rehabilitation provides equivalent 12-week improvements in functional capacity, cardiorespiratory fitness, and body composition compared to centre-based cardiac rehabilitation across major cardiac diagnoses, with potentially superior VO2 peak benefits in atrial fibrillation patients.
Answers are grounded in this paper and cite their sources.
Supports expanded access via home-based cardiac rehabilitation; confirms equivalence to centre-based programs with AF-specific advantages.
Aims: Centre-based cardiac rehabilitation (CBCR) uptake remains globally suboptimal due to logistical and geographic barriers. Home-based cardiac rehabilitation (HBCR) has emerged as an alternative model to mitigate these limitations. We aimed to quantify the comparative efficacy of HBCR versus CBCR across aerobic capacity, functional mobility, and body composition through a meta-analysis of randomized controlled trials (RCTs). Methods and results: Systematic review of Embase, Scopus, and PubMed identified 11 RCTs enrolling 720 patients (355 HBCR, 365 CBCR) with coronary artery disease, heart failure, and atrial fibrillation (AF). The primary endpoints were 12-week peak oxygen uptake (VO 2 peak), six-minute walk distance (6MWD), and body mass index (BMI). Random-effects models generated pooled mean differences (MD) with 95% confidence intervals (CI). Overall, HBCR and CBCR achieved equivalent improvements in VO 2 peak (MD 0.71 mL/kg/min, 95% CI –0.66 to 2.08; P = 0.27; I 2 = 52.3%), 6MWD (MD 2.47 m, 95% CI –40.20 to 45.14; P = 0.87; I 2 = 0%), and BMI (MD –0.03 kg/m 2 , 95% CI –0.36 to 0.30; P = 0.82; I 2 = 0%). Significant diagnostic subgroup heterogeneity was observed for VO 2 peak (P = 0.003). Specifically, in the AF subgroup, HBCR demonstrated superior VO 2 peak gains compared to CBCR (MD 4.00 mL/kg/min, 95% CI 1.82 to 6.18; P < 0.001). Conclusion: Across major cardiac diagnoses, HBCR achieves equivalent 12-week improvements in functional capacity and body composition compared to CBCR. In patients with AF specifically, HBCR may confer superior cardiorespiratory benefit, warranting prospective confirmatory investigation. These findings robustly support HBCR as a clinically non-inferior modality for broadening equitable cardiac rehabilitation access at scale.
No takes yet. Share an insight, caveat, or question.
Rai et al. (2026) conducted a meta-analysis in Coronary artery disease, heart failure, and atrial fibrillation (n=720). Home-based cardiac rehabilitation (HBCR) vs. Centre-based cardiac rehabilitation (CBCR) was evaluated on 12-week peak oxygen uptake (VO2 peak), six-minute walk distance (6MWD), and body mass index (BMI) (MD 0.71 mL/kg/min, 95% CI -0.66 to 2.08, p=0.27). Home-based cardiac rehabilitation achieved equivalent 12-week VO2 peak improvements vs. centre-based rehab, with superior gains in AF.
Synapse has enriched 10 related papers. Consider them for comparative context: